Turn ISTH data into business-critical insights. 30 high-prescribing hematologists analyze 10 Hemophilia A abstracts to help you prepare for what’s next. Take the guesswork out of understanding changes in prescribing behavior for BAY 2599023, BAY 94-9027,  concizumab, emicizumab, eptacog beta, marzeptacog alfa (activated), valoctocogene roxaparvovec (BMN270), and SPK-8011 among others. Get your 60+ slide report.

Hemophilia A Report ISTH 2021

International Society on Thrombosis and Haemostasis 2021

Virtual Meeting
July 17 to July 21

Share: